Escient Pharmaceuticals
San Diego
About Escient Pharmaceuticals
Escient Pharmaceuticals is a provider of bio-technical research and development services intended to focus on the advancement of first-in-class G Protein-Coupled Receptor targeted drugs. Its services focus on offering therapies for neuro-immuno-inflammatory and autoreactive diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $237.5M
- Funding stage: M&A
- Last round: Series C (Nov 2022)
- Website: escientpharma.com
- Phone: 858.617.8220
Industries & Categories
Biotechnology, Medical, Neuroscience, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/escient-pharmaceuticals-74925 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.